BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta

Reuters
09 Apr
BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta

April 9 (Reuters) - Argent BioPharma Ltd RGT.AX:

  • STRATEGIC COLLABORATION AGREEMENT FOR ARGENT EU GMP FACILITY IN MALTA

  • STRATEGIC COLLABORATION GRANTING DAVID TRADING EXCLUSIVE RIGHTS TO OPERATE RGT'S FACILITY IN MALTA

  • DAVID TRADING GRANTED EXCLUSIVE, IRREVOCABLE OPTION TO ACQUIRE 100% OF FACILITY COMPANY'S SHARES

Further company coverage: RGT.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10